Skip to content

Clinical Evaluation of Two Toric Soft Contact Lenses

Clinical Evaluation of Biomedics Monthly Toric and Avaira Vitality Toric

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06490302
Enrollment
40
Registered
2024-07-08
Start date
2024-05-24
Completion date
2024-06-28
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The aim of this study is to compare the short-term clinical performance of two toric contact lenses.

Detailed description

The aim of this study is to evaluate the short-term clinical performance of two toric contact lenses when compared to each other after 15 minutes of daily wear each.

Interventions

15 minutes of daily wear

15 minutes of daily wear

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Is between 18 and 40 years of age (inclusive) * Has had a self-reported visual exam in the last two years. * Is an adapted soft contact lens wearer. * Is not a habitual wearer of either study lens. * Has a contact lens spherical prescription between +5.00 to -9.00 (inclusive) best corrected visual acuity of 20/30 or better in either eye. * Have contact lens prescription of no less than -0.75D of astigmatism and no more than -2.25D in both eyes. * Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye. * Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses. * Has clear corneas and no active ocular disease. * Has read, understood and signed the informed consent letter. * Patient contact lens refraction should fit within the available parameters of the study lenses. * Is willing to comply with the wear schedule (at least 5 days per week, \>8 hours/day assuming there are no contraindications for doing so). * Is willing to comply with the visit schedule.

Exclusion criteria

* Has a CL prescription outside the range of the available parameters of the study lenses. * Has a spectacle cylinder less than -0.75D or more than -2.50D of cylinder in either eye. * Slit lamp findings that would contraindicate contact lens wear such as: 1. Pathological dry eye or associated findings 2. Pterygium, pinguecula, or corneal scars within the visual axis 3. Neovascularization \> 0.75 mm in form of the limbus 4. Giant papillary conjuctivitis (GCP) worse than grade 1 5. Anterior uveitis or iritis (past or present) 6. Seborrheic eczema, seborrheic conjunctivitis 7. History of corneal ulcers or fungal infections 8. Poor personal hygiene 9. Has a known history of corneal hypoesthesia (reduced corneal sensitivity) 10. Has aphakia, keratoconus or a highly irregular cornea. 11. Has Presbyopia or has dependence on spectacles for near work over the contact lenses. 12. Has undergone corneal refractive surgery. 13. Is participating in any other type of eye related clinical or research study.

Design outcomes

Primary

MeasureTime frameDescription
Overall Fit AcceptanceAt the end of 15 minutes of daily wearOverall lens fit acceptance was measured on a scale from 0-4 (0= Should not be worn, 4= Perfect)

Countries

Mexico

Participant flow

Pre-assignment details

Forty participants were screened. All the participants who were eligible in the study were included in the analysis. (n=40)

Participants by arm

ArmCount
All Study Participants
Includes all Study Participants
40
Total40

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous25.6 years
STANDARD_DEVIATION 7.6
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
28 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 40
other
Total, other adverse events
0 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 40

Outcome results

Primary

Overall Fit Acceptance

Overall lens fit acceptance was measured on a scale from 0-4 (0= Should not be worn, 4= Perfect)

Time frame: At the end of 15 minutes of daily wear

ArmMeasureValue (MEAN)Dispersion
Lens A (Ocufilcon D)Overall Fit Acceptance3.6 units on a scaleStandard Deviation 0.8
Lens B (Fanfilcon A)Overall Fit Acceptance3.7 units on a scaleStandard Deviation 0.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026